Physician
Familycare Medical Group, PC
Familycare Medical Group, PC was paid $9.20M by Medicaid between Jan 2018 and Nov 2024, across 90 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
33Billing provider infoFAMILYCARE MEDICAL GROUP, PC
SYRACUSE, NY 13204
SYRACUSE, NY 13204
33aNPI1447212063assigned 04/06/2006
33bProvider typeInternal Medicine Physician
28Total paid$9.20M
24GClaims149,486
24DCodes billed90
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#28 of 6,049
Median peer was paid$11K
This provider vs. median813×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,533 | $1.10M | |
| 2019 | 25,778 | $1.39M | |
| 2020 | 25,091 | $1.48M | |
| 2021 | 24,547 | $1.69M | |
| 2022 | 20,642 | $1.55M | |
| 2023 | 22,323 | $1.34M | |
| 2024incomplete | 11,572 | $649K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 49,144 | 44,843 | $5.18M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 32,366 | 29,835 | $2.37M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 4,644 | 3,658 | $230K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.7% | 2,197 | 1,054 | $155K |
| 99443 | 1.2% | 1,058 | 741 | $111K | |
| 80061 | Lipid panel | 1.1% | 8,521 | 8,511 | $101K |
| 80053 | Comprehensive metabolic panel | <1% | 8,818 | 8,766 | $86K |
| 76830 | Ultrasound, transvaginal | <1% | 824 | 823 | $74K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,382 | 8,314 | $58K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 389 | 389 | $56K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,358 | 3,347 | $52K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,769 | 1,766 | $51K |
78 more codes
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 245 | $43K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 441 | $43K |
| 95117 | <1% | 3,919 | $41K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 419 | $40K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,395 | $36K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,050 | $29K |
| 90837 | Psychotherapy session, about an hour | <1% | 188 | $27K |
| 99442 | <1% | 236 | $19K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 944 | $19K |
| 82607 | <1% | 1,192 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,125 | $18K |
| 94729 | <1% | 405 | $17K | |
| 90688 | <1% | 1,173 | $16K | |
| 94726 | <1% | 421 | $16K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 216 | $16K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 115 | $16K |
| 84439 | <1% | 1,753 | $15K | |
| 99406 | <1% | 1,074 | $15K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 151 | $14K |
| 90686 | <1% | 782 | $14K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 122 | $13K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 97 | $11K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 85 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,021 | $10K |
| 95800 | <1% | 99 | $9K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 70 | $9K |
| 86769 | <1% | 255 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 319 | $7K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 226 | $7K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 365 | $7K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 63 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 125 | $7K |
| 99385 | <1% | 54 | $7K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 102 | $6K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 504 | $6K |
| 86803 | <1% | 403 | $5K | |
| 94010 | <1% | 217 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 44 | $5K |
| 80050 | General health panel | <1% | 94 | $4K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 39 | $4K |
| 0011A | <1% | 107 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 132 | $3K |
| 90732 | <1% | 27 | $3K | |
| 99051 | <1% | 407 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $3K |
| 93000 | <1% | 170 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 45 | $2K |
| 87631 | <1% | 18 | $2K | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 128 | $2K |
| 0012A | <1% | 63 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 759 | $2K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 132 | $2K |
| 92557 | <1% | 63 | $2K | |
| 99459 | <1% | 99 | $2K | |
| 99441 | <1% | 37 | $2K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 12 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $1K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 12 | $1K |
| 90656 | <1% | 54 | $977.84 | |
| 92567 | <1% | 71 | $973.92 | |
| 82248 | <1% | 209 | $953.80 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $777.55 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $777.55 |
| 87081 | <1% | 108 | $638.14 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 21 | $629.90 |
| 92551 | <1% | 135 | $512.57 | |
| 87800 | <1% | 12 | $494.70 | |
| 96127 | <1% | 149 | $399.87 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $244.20 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 25 | $192.45 |
| 82043 | <1% | 29 | $144.50 | |
| 82570 | <1% | 29 | $133.34 | |
| 81002 | <1% | 37 | $115.92 | |
| 96160 | <1% | 38 | $113.96 | |
| 81003 | <1% | 30 | $58.68 | |
| 99173 | <1% | 114 | $39.11 | |
| 91301 | 0% | 52 | $0.00 | |
| 1111F | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRODEY, MITCHELL (PRESIDENT)